Literature DB >> 22477592

A comparative study of restenosis rates in bare metal and drug-eluting stents.

Shilpi Mohan1, Anil Dhall.   

Abstract

BACKGROUND: Various studies have been performed throughout the world on the rate of restenosis using bare metal stents (BMS) and drug-eluting stents (DES). The prohibitive costs associated with DES generally dictate the type of stent used, especially in developing countries. Therefore, there was a need for a study to assess the effect of various risk factors on restenosis in BMS and DES in the Indian context. A study was performed in the premier institution of the Indian Armed Forces, the Army Hospital (Research and Referral), New Delhi, India, under the aegis of the Indian Council of Medical Research (New Delhi). The profile of patients in the armed forces is inherently diverse in terms of demography, ethnicity, genetics, etc, which reflects the diverse and varied nature of the population in India. METHODS AND
RESULTS: A total of 130 patients were included in the present study. Follow-up after stent implantation was scheduled for six to nine months following the procedure to assess symptoms, drug compliance, and treadmill test and coronary angiography results, and to ascertain the incidence of restenosis. However, only 80 patients returned for follow-up and, therefore, the final analysis was based on these patients. They were segregated into BMS (n=41) and DES (n=39) groups. Restenosis occurred in 29 patients (36.3%). Nine of 39 patients with DES (23.1%) and 20 of 41 patients with BMS (48.8%) developed restenosis. There was a statistically significant relationship between restenosis and female sex, clinical presentation before intervention and at the time of follow-up evaluation (unstable angina), hypertension, positive stress test and compliance with medical therapy (P<0.05). No statistically significant relationship was observed between restenosis and age, diabetes, smoking, obesity and diet (P>0.05).
CONCLUSIONS: DES appear to reduce the restenosis rate and clinical end points, and appear to be more cost effective than BMS. Patient-related factors (eg, sex, hypertension and unstable angina) are important variables that affect the restenosis rate. Noninvasive stress testing had high positive and negative predictive values. Therefore, based on the present study, noninvasive stress testing is suggested before routine angiography at follow-up, which will reduce the need for repeat coronary angiography.

Entities:  

Year:  2010        PMID: 22477592      PMCID: PMC3005409          DOI: 10.1055/s-0031-1278368

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  38 in total

1.  Direct stenting appears as effective as stenting following predilatation.

Authors:  Tim Süselbeck; Debbie Singh
Journal:  Evid Based Cardiovasc Med       Date:  2006-05-26

2.  Obesity and clinical restenosis after coronary stent placement.

Authors:  Jamal S Rana; Murray A Mittleman; Kalon K Ho; Donald E Cutlip
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

Review 3.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

4.  Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.

Authors:  M P Savage; J S Douglas; D L Fischman; C J Pepine; S B King; J A Werner; S R Bailey; P A Overlie; S H Fenton; J A Brinker; M B Leon; S Goldberg
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

5.  Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.

Authors:  David J Moliterno; Steven J Yakubov; Peter M DiBattiste; Howard C Herrmann; Gregg W Stone; Carlos Macaya; Franz-Josef Neumann; Diego Ardissino; Jean-Pierre Bassand; Lynn Borzi; Alan C Yeung; Katherine A Harris; Laura A Demopoulos; Eric J Topol
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

6.  Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test.

Authors:  J R Bengtson; D B Mark; M B Honan; D S Rendall; T Hinohara; R S Stack; M A Hlatky; R M Califf; K L Lee; D B Pryor
Journal:  Am J Cardiol       Date:  1990-01-01       Impact factor: 2.778

7.  Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).

Authors:  Julinda Mehilli; Adnan Kastrati; Josef Dirschinger; Lena Etzel; Hildegard Bollwein; Jürgen Pache; Helmut Schühlen; Nicolas Von Beckerath; Melchior Seyfarth; Claus Schmitt; Albert Schömig
Journal:  Catheter Cardiovasc Interv       Date:  2004-02       Impact factor: 2.692

8.  Restenosis after successful coronary angioplasty in patients with single-vessel disease.

Authors:  P P Leimgruber; G S Roubin; J Hollman; G A Cotsonis; B Meier; J S Douglas; S B King; A R Gruentzig
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

Review 9.  Postangioplasty restenosis rate between segments of the major coronary arteries.

Authors:  W R Hermans; B J Rensing; J C Kelder; P J de Feyter; P W Serruys
Journal:  Am J Cardiol       Date:  1992-01-15       Impact factor: 2.778

10.  Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions.

Authors:  A G Violaris; R Melkert; P W Serruys
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

View more
  7 in total

1.  Reduced histologic neo in-stent restenosis after use of a paclitaxel-coated cutting balloon in porcine coronary arteries.

Authors:  Denise Traxler; Rayyan Hemetsberger; Andreas Spannbauer; Katrin Zlabinger; Alfred Gugerell; Dominika Lukovic; Ljubica Mandic; Noemi Pavo; Johannes Winkler; Mariann Gyöngyösi
Journal:  Histol Histopathol       Date:  2019-10-24       Impact factor: 2.303

Review 2.  Human pluripotent stem cells: Towards therapeutic development for the treatment of lifestyle diseases.

Authors:  Miwako Nishio; Masako Nakahara; Akira Yuo; Kumiko Saeki
Journal:  World J Stem Cells       Date:  2016-02-26       Impact factor: 5.326

3.  Electrospraying an enabling technology for pharmaceutical and biomedical applications: A review.

Authors:  Sunil Kumar Boda; Xiaoran Li; Jingwei Xie
Journal:  J Aerosol Sci       Date:  2018-04-09       Impact factor: 3.433

Review 4.  Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis.

Authors:  Rui-Ting Hu; Jie Liu; You Zhou; Bang-Li Hu
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

5.  The risk for subsequent coronary interventions in a local Polish population.

Authors:  Jaroslaw Hiczkiewicz; Paweł Burchardt; Konrad Pieszko; Jan Budzianowski; Dariusz Hiczkiewicz; Bogdan Musielak; Anna Winnicka-Zielinska; Daria Adamczak; Wojciech Faron; Janusz Rzeźniczak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

6.  An agent-based model of the response to angioplasty and bare-metal stent deployment in an atherosclerotic blood vessel.

Authors:  Antonia E Curtin; Leming Zhou
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

7.  Evaluation of relationship between common carotid artery intima-media thickness and coronary in-stent restenosis: A case-control study.

Authors:  Penta Bhavanadhar; Yerrabandi Venkata Subba Reddy; Adikeshava Naidu Otikunta; Ravi Srinivas
Journal:  Interv Med Appl Sci       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.